Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer

J. Kinoshita, K. Kitamura, A. Kabashima, H. Saeki, S. Tanaka, K. Sugimachi

研究成果: ジャーナルへの寄稿学術誌査読

140 被引用数 (Scopus)

抄録

Vascular endothelial growth factor-C (VEGF-C) is a specific ligand which induces lymphangiogenesis. We examined the expression of VEGF-C protein to determine its role in the progression of breast cancer. Immunohistochemical analysis revealed that VEGF-C was overexpressed in 39 of 98 breast cancer specimens (39.8%) but not in adjacent normal mammary glands. The expression of VEGF-C showed a significant correlation with lymphatic vessel invasion (p = 0.0004). It is noteworthy that the 5-year disease free survival rate of the VEGF-C positive group was significantly poorer than that of negative group (p = 0.0356). We suggest that as expression of VEGF-C is not implicated in lymphatic spread, it may prove to be a promising marker to predict the recurrence of breast cancer.

本文言語英語
ページ(範囲)159-164
ページ数6
ジャーナルBreast Cancer Research and Treatment
66
2
DOI
出版ステータス出版済み - 2001
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル